Form 8-K Vir Biotechnology, Inc. For: Apr 15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Vir Biotechnology Inc. (VIR) Announces CFO Departure
April 18, 2024 8:48 AM EDTOn April 15, 2024, Sung Lee, Executive Vice President and Chief Financial Officer of Vir Biotechnology Inc. (NASDAQ: VIR), informed the Company that he will be stepping down from his role, effective May 3, 2024, to pursue another career opportunity. The Company has initiated a search for... More
